Bitcoin Hits All-Time High: Key Takeaways and Impact of SEC Approved Spot ETFsby John Darbie 05.03.2024Bitcoin surpasses previous all-time high of $69,000, driven by high demand, low supply, and SEC approval of spot bitcoin ETFs. ...
Bragg Gaming Expands with Golden Nugget in Michiganby Mark Eisenberg 23.02.2024Gaming technology provider Bragg Gaming Group has launched its latest games and Remote Game Server technology at Golden Nugget in ...
Uber vs. Bird: Ride-Sharing vs. Electric Scooter Services SWOT Analysisby Lilu Anderson 22.02.2024Discover the battle between Uber and Bird for urban mobility supremacy in this in-depth SWOT analysis. Explore the future of ...
Insight Timer Faces Apple’s 30% Commission Demandby Lilu Anderson 22.02.2024The CEO of Insight Timer, a meditation app with 25 million installs, is frustrated with Apple's commission on donations. The ...
Google Unveils Gemma: Laptop-Friendly Open Source AIby Lilu Anderson 22.02.2024Google has released Gemma, a language model that can be used to create chatbots, content generation tools, and more. They ...
Uber vs. Lime: Ride-Sharing vs. Scooter-Sharing Services SWOT Comparisonby Lilu Anderson 21.02.2024Discover the ultimate SWOT showdown between Uber and Lime in the urban mobility arena. Uncover the strengths, weaknesses, opportunities, and ...
Amazon Joins Dow Jones, Walgreens Booted – Bloombergby Mark Eisenberg 21.02.2024Amazon.com is set to join the Dow Jones Industrial Average, replacing Walgreens Boots Alliance, while Uber Technologies will replace JetBlue ...
Amazon Stock Surges On Dow Jones Addition: Insights on AMZN Market Moveby Mark Eisenberg 21.02.2024Amazon.com Inc's shares are trading higher after the company was selected to join the Dow Jones Industrial Average, replacing Walgreens.
Market Concerns Rise Amid Stock Rallyby Terry Bingman 20.02.2024Stocks are reaching new highs, driven by strong earnings and optimism about the economy. However, inflation and interest rates pose ...
Medicxi Launches Alys Pharmaceuticals in $100m Seed Fundingby Mark Eisenberg 19.02.2024Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...